These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Sonis ST; Lindquist L; Van Vugt A; Stewart AA; Stam K; Qu GY; Iwata KK; Haley JD Cancer Res; 1994 Mar; 54(5):1135-8. PubMed ID: 8118793 [TBL] [Abstract][Full Text] [Related]
43. Chemopreventive effects of FITOPROT against 5-fluorouracil-induced toxicity in HaCaT cells. Dos Santos Filho EX; da Silva ACG; de Ávila RI; Batista AC; Marreto RN; Lima EM; de Oliveira CMA; Mendonça EF; Valadares MC Life Sci; 2018 Jan; 193():300-308. PubMed ID: 28962868 [TBL] [Abstract][Full Text] [Related]
45. High fat diet-induced obesity exacerbates hematopoiesis deficiency and cytopenia caused by 5-fluorouracil via peroxisome proliferator-activated receptor γ. Li Y; Zhu S; Zhang Y; Liu T; Su L; Zhang Q; Luo Y Exp Hematol; 2018 Apr; 60():30-39.e1. PubMed ID: 29305999 [TBL] [Abstract][Full Text] [Related]
46. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180 [TBL] [Abstract][Full Text] [Related]
47. Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice. Sun H; Zhou Y; Ma R; Zhang J; Shan J; Chen Y; Li X; Shan E Eur J Pharm Sci; 2022 Jun; 173():106182. PubMed ID: 35405270 [TBL] [Abstract][Full Text] [Related]
48. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells. Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296 [TBL] [Abstract][Full Text] [Related]
49. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
50. Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model. de Araújo AA; Varela H; de Medeiros CA; de Castro Brito GA; de Lima KC; de Moura LM; de Araújo Júnior RF PLoS One; 2015; 10(2):e0116799. PubMed ID: 25689279 [TBL] [Abstract][Full Text] [Related]
51. A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model. Mangoni M; Sottili M; Gerini C; Bonomo P; Bottoncetti A; Castiglione F; Franzese C; Cassani S; Greto D; Masoni T; Meattini I; Pallotta S; Passeri A; Pupi A; Vanzi E; Biti G; Livi L Lung Cancer; 2015 Dec; 90(3):405-9. PubMed ID: 26791799 [TBL] [Abstract][Full Text] [Related]
52. Increased expression of 5-HT3 and NK 1 receptors in 5-fluorouracil-induced mucositis in mouse jejunum. Matsumoto K; Nakajima T; Sakai H; Kato S; Sagara A; Arakawa K; Tashima K; Narita M; Horie S Dig Dis Sci; 2013 Dec; 58(12):3440-51. PubMed ID: 23695873 [TBL] [Abstract][Full Text] [Related]
53. A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice. Yan XX; Li HL; Zhang YT; Wu SY; Lu HL; Yu XL; Meng FG; Sun JH; Gong LK Acta Pharmacol Sin; 2020 Mar; 41(3):348-357. PubMed ID: 31506573 [TBL] [Abstract][Full Text] [Related]
54. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821 [TBL] [Abstract][Full Text] [Related]
55. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Logan RM; Stringer AM; Bowen JM; Gibson RJ; Sonis ST; Keefe DM Cancer Chemother Pharmacol; 2009 Jan; 63(2):239-51. PubMed ID: 18351341 [TBL] [Abstract][Full Text] [Related]
56. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis. Zhang YF; Zou XL; Wu J; Yu XQ; Yang X Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949 [TBL] [Abstract][Full Text] [Related]
57. Effects of Onchung-eum, an Herbal Prescription, on 5-Fluorouracil-Induced Oral Mucositis. Park JW; Oh J; Ko SJ; Chang MS; Kim J Integr Cancer Ther; 2018 Dec; 17(4):1285-1296. PubMed ID: 30296855 [TBL] [Abstract][Full Text] [Related]
58. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway. Nuwormegbe SA; Sohn JH; Kim SW Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722 [TBL] [Abstract][Full Text] [Related]
59. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis. Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902 [TBL] [Abstract][Full Text] [Related]
60. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. Tsavaris N; Caragiauris P; Kosmidis P Eur J Surg Oncol; 1988 Oct; 14(5):405-6. PubMed ID: 3181443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]